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ABSTRACT Myosin subfragment 1 (S1) can be specifically modified at Lys-553 with the fluorescent probe FHS (6-
[fluorescein-5(and 6)-carboxamido]hexanoic acid succinimidyl ester) (Bertrand, R., J. Derancourt, and R. Kassab. 1995.
Biochemistry. 34:9500–9507), and solvent quenching of FHS-S1 with iodide has been shown to be sensitive to actin binding
at low ionic strength (MacLean, Chrin, and Berger, 2000. Biophys. J. 000–000). In order to extend these results and examine
the fraction of actin-bound myosin heads within the myofilament lattice during calcium activation, we have modified skeletal
muscle myofibrils, mildly cross-linked with EDC (1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide) to prevent shortening, with
FHS. The myosin heavy chain appears to be the predominant site of labeling, and the iodide quenching patterns are
consistent with those obtained for myosin S1 in solution, suggesting that Lys-553 is indeed the primary site of FHS
incorporation in skeletal muscle myofibrils. The iodide quenching results from calcium-activated FHS-myofibrils indicate that
during isometric contraction 29% of the myosin heads are strongly bound to actin within the myofilament lattice at low ionic
strength. These results suggest that myosin can be specifically modified with FHS in more complex and physiologically
relevant preparations, allowing the real time examination of cross-bridge interactions with actin in in vitro motility assays and
during isometric and isotonic contractions within single muscle fibers.
INTRODUCTION
Actin and myosin interact in an ATP-dependent manner to
produce force and motion during muscle contraction. The
cyclic nature of this interaction requires that myosin change
its affinity for actin by several orders of magnitude at
different stages of its ATPase cycle. In the ATP and ADP 
Pi (i.e., the products of hydrolysis) states of the ATPase
cycle myosin binds weakly to actin, with an association
constant of 103 M1 (Stein et al., 1979). Upon the release
of phosphate myosin undergoes a conformational change,
greatly increasing its affinity for actin and proceeding
through its powerstroke to generate myofilament sliding
and/or force generation. In the post-powerstroke states
(ADP and rigor (i.e., nucleotide-free)) myosin binds
strongly to actin, with association constants in the range of
106-107 M1 (Greene and Eisenberg, 1980). While the
interaction between actin and myosin described above is
well understood from solution studies of purified proteins,
the interaction between actin and myosin within the myo-
filament lattice of muscle fibers and myofibrils is not as
well characterized.
Mechanical stiffness measurements have been tradition-
ally used to examine the binding of myosin cross-bridges to
actin in intact and skinned muscle fibers. Goldman and
Simmons (1977) originally reported that 80% of the my-
osin cross-bridges are strongly bound to actin in isometri-
cally contracting muscle fibers. However, other studies have
indicated that the fraction of actin-bound cross-bridges in
isometrically contracting muscle fibers may actually be
much lower than 80%. Cooke et al. (1982) demonstrated
using EPR spectroscopy that only 20% of the myosin heads
adopt the rigor-like orientation expected for strongly bound
cross-bridges in spin-labeled, isometrically contracting,
skinned muscle fibers. Consistent with this result, proteo-
lytic digestion experiments on isometrically contracting,
cross-linked myofibrils have suggested that only 25% of the
myosin cross-bridges are bound to actin at physiological
ionic strength (Duong and Reisler, 1989; Berger and
Thomas, 1993). The discrepancy in the fraction of actin-
bound myosin heads measured in actively contracting mus-
cle fibers and myofibrils may be due, in part, to the under-
lying assumption in the stiffness measurements that most of
the sarcomeric compliance resides within the cross-bridge
itself. This assumption has recently been challenged by
results from both mechanical (Higuchi et al., 1995) and
high-resolution x-ray diffraction (Huxley et al., 1994; Wak-
abayashi et al., 1994) studies on actively contracting muscle
fibers, indicating that less than half of the sarcomere’s
compliance actually resides within the cross-bridges. More
recent mechanical stiffness measurements have attempted to
account for the existence of these non-cross-bridge compli-
ances. For example, Linari et al. (1998) have reduced the
fraction of actin-bound cross-bridges in isometrically con-
tracting muscle fibers to 43%, but this is still significantly
higher than the values of 20–25% reported using other
techniques.
Accurate determination of the fraction of actin-bound
cross-bridges during unloaded myofilament sliding is also
critical to understanding chemomechanical coupling in
muscle. Conventional models of muscle contraction assume
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a tight coupling between the biochemical and mechanical
cycles of acto-myosin, with the hydrolysis of one molecule
of ATP driving a single active interaction between actin and
myosin. However, recent estimates of the chemomechanical
coupling ratio from in vitro motility assays have ranged
from the conventional 1:1 to a  5:1 correspondence be-
tween the number of productive acto-myosin interactions
and the amount of ATP hydrolyzed per myosin molecule.
Much of the controversy surrounding this issue arises from
estimates of the acto-myosin duty cycle (i.e., the fraction of
the ATPase cycle time in which myosin interacts strongly
with actin), which have ranged from very low values of
5% (Uyeda et al., 1990; Harris and Warshaw, 1993) to
very high values up to 80% (Harada et al., 1990). Thus,
experiments that can more directly measure the acto-myosin
interaction under both isometric and isotonic conditions
within the myofilament lattice are clearly needed to resolve
these important issues regarding the molecular mechanism
of muscle contraction.
Lys-553, located in the middle of the second of two
helices in one of the putative actin-binding interface regions
of myosin involving a helix-loop-helix motif in the lower 50
kD subdomain (Rayment et al., 1993; Milligan, 1996; Men-
delson and Morris, 1997), has been specifically modified in
myosin subfragment 1 (S1) by the fluorescent probe FHS
(6-[fluorescein-5(and 6)-carboxamido]hexanoic acid suc-
cinimidyl ester) (Bertrand et al., 1995). In addition, we
show in the accompanying paper (MacLean et al., 2000)
that iodide quenching of the FHS probe in S1 is sensitive to
the strong binding of myosin to actin at low ionic strength.
Thus, solvent quenching of the FHS probe by iodide may be
a useful signal of cross-bridge binding in the intact myofil-
ament lattice (e.g., muscle myofibrils or skinned fibers),
provided that myosin can be specifically labeled at Lys-553
in these more complex preparations as it is in solution. In
the current study we have modified skeletal muscle myofi-
brils with FHS and shown that the myosin heavy chain is the
predominant site of labeling. Furthermore, the iodide
quenching patterns are consistent with those obtained for
myosin S1 in solution (MacLean et al., 2000), suggesting
that Lys-553 is indeed the primary site of FHS incorpora-
tion. Finally, we have demonstrated that iodide quenching
of FHS is capable of detecting actin-bound cross-bridges
within the myofilament lattice at low ionic strength.
METHODS
Chemicals and solutions
FHS was purchased from Molecular Probes (Eugene, OR). 4-Hydroxy-
TEMPO (4-hydroxy-2, 2, 6, 6-tetramethylpiperidinyloxy) and potassium
iodide were purchased from Aldrich (Milwaukee, WI). ATP (adenosine
5-triphosphate), ME (-mercaptoethanol), EDC (1-ethyl-3-[3-(dimeth-
ylamino)propyl]carbodiimide), PPi (tetrapotassium pyrophosphate), tryp-
sin, and all other reagents, at least analytical grade and of the highest purity
possible, were purchased from Sigma (St. Louis, MO). Rigor buffer and all
other experimental solutions contained 10 mM MOPS, 10 mM KCl, 2 mM
MgCl2, 1 mM EGTA, pH 7.0 at 25°C. Relaxing solutions contained an
additional 5 mM MgATP and 24 mM EGTA, and activating solutions
contained an additional 5 mM MgATP and 2 mM CaCl2.
Myofibril isolation and labeling
Myofibrils were prepared from fresh rabbit leg muscle as previously
described (Knight and Trinick, 1982). Myosin concentration in labeled and
unlabeled myofibril solutions was determined using a Coomassie protein
assay (Pierce, Rockford, IL), assuming half the myofibril protein mass was
myosin. Fresh myofibrils were labeled with FHS by a modification of the
method for labeling myosin subfragment 1 (S1) of Bertrand et al. (1995).
This procedure predominantly modifies Lys-553 of the myosin heavy chain
with FHS. Myofibrils were washed with labeling solution (5 mM ATP, 8
mM MgCl2, 25 mM EGTA, 20 mM MOPS, 80 mM KCl, pH 7.0 at 4°C),
and then treated with 0.1% Triton in labeling solution for 10 min on ice
followed by another wash in labeling buffer. The detergent-extracted
myofibrils were then reacted with FHS at a molar ratio of 3:1 (FHS/myosin
head) in labeling buffer for 1 h on ice. The labeling reaction was stopped
with the addition of 10 mM glycine ethyl ester and incubated on ice for 10
min. The myofibrils were then washed with labeling buffer and incubated
on ice for 10 min in labeling buffer plus 20 mM TAPS (pH 8.5) to remove
any FHS that was covalently bound to sites other than Lys-553, including
other amino acids with primary amines or sulfhydryl groups. The myofi-
brils were then given a final 2–3 washes in labeling buffer. Myofibrils were
stored at 20°C in a solution of 5 mM MOPS, 0.5 mM EGTA, 4 mM
MgCl2, and 50% glycerol at pH 7.0. Before use the stored myofibrils were
first washed several times in S1 buffer (10 mM MOPS, 1 mM EGTA, 8
mM MgCl2, pH 7.2 at 4°C).
To ensure that the 50 kD tryptic fragment of myosin containing Lys-553
was the primary site of FHS incorporation within the myofibrils, limited
tryptic digestion was carried out on the FHS-labeled myofibrils. Myofibrils
were concentrated to 15 mg/ml and resuspended in a small volume of S1
buffer plus 5 mM MgPPi. Trypsin was added at a ratio of 1 mg to 500 mg
myofibrils. At various time points up to a total of 15 min, 20 l of reaction
mixture was added to a solution of 75 l sample buffer (63 mM Tris-HCl,
pH 6.8, 10.5% glycerol, 0.02% SDS), 2 l 14.2 M -mercaptoethanol, and
5 l 0.25 M Tris-HCl plus 2 M Urea, pH 8.0, and then boiled for 4 min in
preparation for SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Di-
gested and non-digested samples of FHS-myofibrils were run on either a
7.5% or 4–20% gradient SDS-polyacrylamide gel by the method of Laem-
mli (1970). Fluorescent labeling of myofibrillar proteins was visualized on
a UV light box, and the gel was then Coomassie stained for direct
visualization. Photographs of the fluorescently imaged gels were digitized
and quantified on a Discovery Series desktop scanner interfaced with
Quantity One analysis software (v. 2.4, PDI, Huntington Station, NY)
(Berger et al., 1996).
Actively contracting myofibrils were first mildly cross-linked with EDC
under rigor conditions to prevent shortening as described previously
(Duong and Reisler, 1989; Berger and Thomas, 1993). Briefly, myofibrils
were adjusted to 1 mg/ml in 0.1 M NaCl/0.1 M MES, pH 6.5 (4°C), and
EDC was added to a final concentration of 10 mM. The myofibrils were
constantly stirred on ice for 30 min during the cross-linking reaction. The
reaction was stopped with the addition of 0.3 M ME, and the myofibrils
were washed several times with S1 buffer.
ATPase assays
Myofibrillar ATPase assays were performed under relaxing or activating
conditions as described previously (Ludescher and Thomas, 1988). The
myofibrillar suspension (0.2–0.5 mg/ml) was continuously stirred in a 1-ml
incubation vial containing the appropriate buffer in a thermostatically
controlled water bath at 25°C. The reaction was initiated by the addition of
1450 Cooper et al.
Biophysical Journal 78(3) 1449–1457
5 mMATP, and small (50 l) aliquots were removed at 1-min intervals and
assayed colorimetrically for inorganic phosphate by the method of Lanzetta
et al. (1979). The steady-state rate of phosphate production per myosin
head per second (assuming 50% of the myofibrillar mass is myosin) was
determined by a linear regression analysis of the data from the linear phase
of the reaction during the first 10 min of the incubation.
Fluorescence spectroscopy
Fluorescence emission spectra were collected with a Quantamaster flu-
orometer (Photon Technology International, South Brunswick, NJ). Sam-
ples of FHS-myofibrils were excited by a 75 W xenon arc lamp through a
single-grating monochromator at 470 nm. The emitted fluorescence was
collected from 500 to 600 nm using a single-grating monochromator
interfaced to a PMT and computer for data storage and analysis. Slit widths
were 2 nm.
Solvent quenching experiments were performed at 25°C with 1–2
mg/ml FHS-myofibrils in rigor, relaxing, or activating conditions. Some
experiments, as noted in the text, also included an additional 150 mM KCl.
Fluorescence values were taken at the peak of the emission spectrum for
each sample, usually at 525 nm. After an initial reading in the absence of
quencher (F0), quencher was added to the sample in increasing amounts
and the remaining fluorescence (F) determined. Typically, 4-hydroxy-
TEMPO was added in increments of 10–20 mM up to 80 mM, and
potassium iodide was added in increments of 5–10 mM up to 40 mM. Ionic
strength was adjusted when necessary with KCl. The final concentration of
potassium iodide added was limited by its contribution to the ionic strength
of our solutions. All spectra were corrected for the added volume of the
quencher and inner filter effects when necessary. The relative fluorescence
change F0/F was then plotted versus the quencher concentration for each
experiment to asses the accessibility of FHS at Lys-553 of myosin to the
various solvent quenchers (Q). The resulting plots were fit to the Stern-
Volmer relationship for dynamic solvent quenching using a linear least-
squares routine in SigmaPlot (v5.0, SPSS Inc., Chicago, IL):
F0/F KSVQ 1 (1)
where the slope, KSV, is the Stern-Volmer constant that qualitatively
describes the degree of accessibility of the fluorescent probe (FHS) to the
solvent (Eftink and Ghiron, 1976). For actively contracting myofibrils, the
observed Stern-Volmer constant (KSV-Act) was assumed to be composed of
two components; one arising from detached cross-bridges with a Stern-
Volmer constant equal to that observed with relaxed myofibrils (KSV-Rel),
and one arising from actin-bound cross-bridges with a Stern-Volmer con-
stant equal to that observed with rigor myofibrils (KSV-Rig). Therefore,
KSV-Act was assumed to be a linear combination of KSV-Rig, weighted by the
fraction of actin-bound cross-bridges (fB), and KSV-Rel, weighted by the
fraction of detached cross-bridges (1  fB):
KSV-Act fB  TKSV-Rig 	1 fB
  KSV-Rel (2)
Thus, the fraction of actin-bound cross-bridges in actively contracting
myofibrils can be determined by:
fB 	KSV-Act KSV-Rel
/	KSV-Rig KSV-Rel
 (3)
RESULTS
Labeling of myofibrils with FHS
Skeletal muscle myofibrils were selectively labeled with
FHS with 75% of the total fluorescence being incorpo-
rated into the myosin heavy chain as determined by scan-
ning densitometry (Fig. 1 A). Smaller amounts of fluores-
cence were incorporated into an unidentified large
molecular weight protein, -actinin, troponin T, tropomyo-
sin, and light chain 1 and 2. However, as can be seen clearly
in Fig. 1 A, actin was not labeled at all. Furthermore, limited
tryptic digestion of myosin in relaxed myofibrils shows
significant labeling of the 75 kD fragment of myosin sub-
fragment 1 (S1), consistent with the primary site of modi-
fication being the 50 kD fragment containing Lys-553 (Fig.
1 B). The myosin rod, which is rich in lysine and included
in the 150 kD tryptic fragment of myosin, was also labeled
by FHS, but to a lesser extent than the 75 kD tryptic
fragment of myosin containing Lys-553. Finally, rigor myo-
fibrils were protected from trypsinolysis at the 50/20 kD
junction, as evidenced by the relative lack of appearance of
the 75 kD fragment (Fig. 1 B). Thus, myosin appears to bind
normally to actin under rigor conditions in FHS-modified
myofibrils.
The steady-state ATPase activities of relaxed and cal-
cium-activated myofibrils were 0.64  0.03 s1 and 3.0 
0.4 s1, respectively (Table 1). FHS modification slightly
increased the ATPase activity of relaxed myofibrils to
0.80  0.04 s1, and slightly decreased the ATPase activity
of calcium-activated myofibrils to 2.5  0.3 s1 (Table 1).
Thus, FHS modification did not greatly alter the ability of
myofibrils to hydrolyze ATP in a calcium-dependent man-
ner. In fact, the effects of FHS modification on the ATPase
activity of skeletal muscle myofibrils is similar to that
observed for FHS-modified skeletal muscle myosin S1
(Bertrand et al., 1995; MacLean et al., 2000). EDC cross-
linking increased the ATPase activity of FHS-myofibrils to
3.6  0.2 s1 (Table 1). This modest increase is consistent
with previous studies, which have shown that only a small
fraction (25%) of the myosin heads are cross-linked to
actin in this preparation (Glyn and Sleep, 1985; Duong and
Reisler, 1989; Berger and Thomas, 1993). Nevertheless, this
level of cross-linking was sufficient to prevent active short-
ening of the FHS myofibrils, as observed by phase-contrast
microscopy.
Solvent quenching in rigor and
relaxed FHS-myofibrils
Fluorescence quenching experiments were carried out to
examine the solvent accessibility of FHS in rigor and re-
laxed FHS-myofibrils. These results are summarized in
Table 2. The fluorescence from FHS was effectively
quenched in both rigor (KSV 24.3 0.3 M
1) and relaxed
FHS-myofibrils (KSV  27.5  0.3 M
1) by the neutral
quencher 4-hydroxy-TEMPO at low ionic strength (Fig. 2).
Potassium iodide was a less effective quencher of FHS
fluorescence than 4-hydroxy-TEMPO at both low ionic
strength and with the addition of high salt (150 mM KCl).
At low ionic strength the binding of cross-bridges to actin
under rigor conditions (KSV  2.6  0.7 M
1) protects a
significant portion of the FHS fluorescence in myofibrils
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from quenching by iodide relative to relaxed conditions
(KSV  9.1  0.5 M
1) (Fig. 3). Furthermore, upon the
addition of high salt (150 mM KCl), the protection offered
from iodide quenching by actin binding in rigor myofibrils
was virtually abolished (KSV  3.5  0.6 M
1 in rigor
FHS-myofibrils and KSV  4.2  0.4 M
1 in relaxed
FHS-myofibrils; Fig. 4). These results are quite similar to
those obtained from analogous solvent quenching experi-
ments with FHS-S1 (MacLean et al., 2000), in which Lys-
553 is known to be the primary site of modification by FHS
(Bertrand et al., 1995). Together, these results suggest Lys-
553 of the myosin heavy chain is also the primary site of
modification in FHS-myofibrils, and that this probe is not
sterically protected from solvent access when myosin S1 is
bound to actin in a rigor complex. It is more likely that actin
is providing an electrostatic shield from the negatively
charged iodide quencher (MacLean et al., 2000).
Solvent quenching of calcium-activated
FHS-myofibrils
The accessibility of FHS to iodide quenchers in the solvent
was determined at low ionic strength in calcium-activated
FHS-myofibrils mildly cross-linked with EDC to prevent
FIGURE 1 Fluorescent image (top) and Coomassie-stained image (bottom) of (A) 4–20% gradient and (B) 7.5% SDS-polyacrylamide gels of
FHS-labeled skeletal muscle myofibrils. In (B) tryptic digests of rigor (lanes 2–5) and relaxed (lanes 6–9) FHS-myofibrils are shown at the right as a
function of proteolysis time (see Methods). MW molecular weight markers; MHC myosin heavy chain; TnT troponin T; Tm tropomyosin; LC
myosin light chain.
TABLE 1 Myofibrillar Mg2-ATPase activities
Relaxed (s1) Ca2-activated (s1)
Unmodified myofibrils 0.64 0.03 3.0  0.4
FHS-myofibrils 0.80  0.04 2.5  0.3
EDC-FHS-myofibrils n.d. 3.6  0.2
Myofibrillar Mg2-ATPase activities were determined as described in
Methods. Skeletal muscle myofibrils were modified with FHS and/or EDC
as described in Methods. All values are given as the mean  SE (n.d. 
not determined).
TABLE 2 Solvent quenching of FHS-myofibrils
KSV (M
1) fB
4-hydroxy-TEMPO (0 mM KCl)
Relaxed 27.5  0.3 —
Rigor 24.3  0.3 —
Potassium iodide (150 mM KCl)
Relaxed 4.2  0.4 —
Rigor 3.5  0.6 —
Potassium iodide (0 mM KCl)
Relaxed 9.1  0.5 —
Rigor 2.6  0.7 —
Ca2-activated* 7.2  0.6 0.29  0.12
KSV, the Stren-Volmer quenching constant, was determined using Eq. 1. fB,
the fraction of actin-bound cross-bridges, was determined using Eq. 3.
*Ca2-activated myofibrils were mildly cross-linked to prevent shortening.
Values are given as the mean  SE.
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shortening (summarized in Table 2). There was no signifi-
cant difference in the accessibility of FHS probes in cross-
linked versus uncross-linked myofibrils under rigor and
relaxed conditions (data not shown). FHS probes in calci-
um-activated myofibrils were quenched to an intermediate
degree (KSV  7.2  0.6 M
1) between rigor and relaxed
conditions by potassium iodide at low ionic strength (Fig.
5), indicating that a fraction of the probes are protected from
iodide quenching by actin during active cycling of the
cross-bridges. Analysis of these data (Eq. 3) suggests that
only 29  12% of the cross-bridges are bound to actin in
isometrically contracting FHS-myofibrils.
DISCUSSION
Summary of results
Skeletal muscle myofibrils were labeled predominantly on
the myosin heavy chain with the fluorescent probe FHS.
The neutral solvent quencher 4-hydroxy-TEMPO effec-
tively quenched the FHS fluorescence in both rigor and
relaxed myofibrils at low ionic strength, while the nega-
tively charged solvent quencher iodide effectively quenched
the FHS fluorescence in relaxed myofibrils but not rigor
myofibrils at low ionic strength. However, the protection
from iodide quenching in rigor myofibrils was abolished at
higher salt concentrations (150 mM KCl). Together, these
FIGURE 2 Stern-Volmer plots of relaxed (F) and rigor (E) FHS-myo-
fibrils quenched by 4-hydroxy-TEMPO at low ionic strength (0 mM KCl).
KSV, the Stern-Volmer quenching constant, was determined using Eq. 1.
Values are given as the mean  SE.
FIGURE 3 Stern-Volmer plots of relaxed (F) and rigor (E) FHS-myo-
fibrils quenched by potassium iodide at low ionic strength (0 mM KCl).
KSV, the Stern-Volmer quenching constant, was determined using Eq. 1.
Values are given as the mean  SE.
FIGURE 4 Stern-Volmer plots of relaxed (F) and rigor (E) FHS-myo-
fibrils quenched by potassium iodide at high ionic strength (150 mM KCl).
KSV, the Stern-Volmer quenching constant, was determined using Eq. 1.
Values are given as the mean  SE.
FIGURE 5 Stern-Volmer plots of active (F) FHS-myofibrils quenched
by potassium iodide at low ionic strength (0 mM KCl). Shown for com-
parison are the fits to the relaxed (- - -) and rigor (    ) data at low ionic
strength (0 mM KCl) from Fig. 3. KSV, the Stern-Volmer quenching
constant, was determined using Eq. 1. Values are given as the mean  SE.
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results suggest that the fluorescence behavior of FHS-myo-
fibrils is similar to that of FHS-S1 (MacLean et al., 2000),
and that as with FHS-S1, Lys-553 is the predominant resi-
due labeled on the myosin heavy chain (Bertrand et al.,
1995). Finally, iodide quenching of calcium- activated FHS-
myofibrils, mildly cross-linked with EDC to prevent short-
ening, indicates that 29  12% of the myosin heads are
strongly bound to actin during isometric contractions at low
ionic strength.
Fluorescent labeling of FHS-myofibrils
Myofibrils labeled with FHS were predominantly modified
on the myosin heavy chain, with virtually no fluorescence
incorporated into actin. An unidentified large molecular
weight protein, -actinin, troponin T, tropomyosin, and
light chain 1 and 2 were all also labeled by FHS, but to a
much lesser extent than the myosin heavy chain. Both the
S1 and rod portions of myosin were labeled by FHS. Given
that Lys-553 is the primary site of FHS incorporation in
purified skeletal muscle myosin S1 (Bertrand et al., 1995),
it is likely to be the primary site of modification within the
S1 portion of myosin in myofibrils as well. Consistent with
this interpretation is the solvent quenching results from the
FHS-modified myofibrils. The fluorescence from both re-
laxed and rigor FHS-myofibrils is effectively quenched by
4-hydroxy-TEMPO at low ionic strength and iodide at phys-
iological ionic strength (150 mM KCl). However, at low
ionic strength the fluorescence from relaxed FHS-myofi-
brils is effectively quenched by iodide, while the fluores-
cence from rigor FHS-myofibrils is not. The observed pat-
terns of solvent quenching in FHS-myofibrils are similar to
those observed in FHS-labeled myosin S1 in solution, in
which FHS-S1 alone is analogous to the relaxed state in
FHS-myofibrils and FHS-S1 bound to actin in the absence
of nucleotide is analogous to the rigor state in FHS-myofi-
brils (MacLean et al., 2000). The other major site of mod-
ification by FHS in skeletal muscle myofibrils appears the
to be the myosin rod. It is not known which residue(s) are
labeled by FHS in the myosin rod, but given that this portion
of myosin is relatively rich in lysines, this is not an unex-
pected result. The presence of FHS probes outside of the
myosin head does not greatly alter the interpretation of
experiments from calcium-activated FHS-myofibrils, and
most likely is responsible for the small amount of back-
ground fluorescence that is insensitive to cross-bridge bind-
ing to actin in the rigor experiments.
Effects of FHS modification and EDC cross-
linking on myofibrillar function
Modification of skeletal muscle myofibrils by FHS does
slightly alter the enzymatic properties of myosin. The
steady-state ATPase activity of relaxed myofibrils was
slightly increased by FHS labeling (0.64  0.03 s1 to
0.80  0.04 s1), while the steady-state ATPase activity of
calcium-activated myofibrils was slightly decreased by FHS
modification (3.0  0.4 s1 to 2.5  0.3 s1). These results
are consistent with effects of FHS modification on purified
skeletal muscle myosin S1 in solution (Bertrand et al., 1995;
MacLean et al., 2000), in which the Mg2-ATPase activity
is slightly elevated and the actin-activated Mg2-ATPase
activity is slightly depressed. The magnitude of the effects
on ATPase activity in the FHS-myofibrils is reduced com-
pared to that in FHS-S1, but this is probably due to a lower
level of FHS modification at Lys-553 in the myofibril
preparation. While it is not possible to accurately determine
the level of FHS incorporation at Lys-553 in the myofibril
preparation, it is unlikely that it reaches the level of 80%
found in FHS-S1 (Bertrand et al., 1995; MacLean et al.,
2000). Finally, FHS modification did not appear to alter
myosin ability to bind strongly to actin in the rigor state, as
evidenced by the lack of proteolytic susceptibility of the
50/20 kD junction in rigor FHS-myofibrils relative to the
relaxed state.
EDC-cross-linked myofibrils were originally introduced
as a solution model for isometrically contracting muscle
fibers by Glyn and Sleep in 1985. Since then, this prepara-
tion has proven to be an excellent system for examining
cross-bridge binding (Duong and Reisler, 1989), rotational
dynamics (Berger and Thomas, 1993), and ATPase kinetics
(Herrmann et al., 1993) in the myofilament lattice under
isometric conditions. The mild cross-linking conditions in
this preparation results in only a small fraction of the
myosin heads being cross-linked to actin (20%), and the
sarcomeres are prevented from shortening in the presence of
millimolar calcium and MgATP as determined by phase
contrast microscopy (Glyn and Sleep, 1985; Duong and
Reisler, 1989; Berger and Thomas, 1993). Consistent with
previous results using non-fluorescent, EDC-cross-linked
myofibrils (Glyn and Sleep, 1985; Duong and Reisler, 1989;
Berger and Thomas, 1993), the calcium-activated Mg2-
ATPase activity of EDC-cross-linked FHS-myofibrils was
almost 50% greater than that of uncross-linked FHS-myo-
fibrils (3.6  0.2 s1 to 2.5  0.3 s1). Thus, EDC-cross-
linked FHS-modified skeletal muscle myofibrils appear to
be a valid model system for examining cross-bridge binding
within the myofilament lattice during calcium-activated,
isometric contractions.
Fraction of actin-bound cross-bridges in
isometrically contracting myofibrils
The fraction of myosin heads strongly bound to actin in
calcium-activated, EDC-cross-linked, FHS-myofibrils was
determined to be 29  12% at low ionic strength by com-
parison to the degree of iodide quenching in relaxed and
rigor FHS-myofibrils using Eq. 3. This calculation is valid
assuming 1) iodide quenching of FHS in relaxed myofibrils
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is indicative of detached cross-bridges, 2) iodide quenching
of FHS in rigor myofibrils is indicative of strongly bound
cross-bridges, 3) strongly bound cross-bridges in calcium-
activated myofibrils behave similarly as strongly bound
cross-bridges in rigor myofibrils with respect to iodide
quenching of FHS, and 4) the fluorescence from FHS
probes in the presence of solvent quenchers in calcium-
activated myofibrils is a linear combination of the fluores-
cence arising from the detached and actin-bound cross-
bridges. The last assumption is certainly valid, because each
population of FHS probes, those on actin-bound or detached
myosin heads, interacts with the iodide ions in the solvent
independently. Inasmuch as solvent quenching affects only
those probes in the excited state, which has a nanosecond
lifetime, only those probes on myosin heads that are bound
to actin are likely to be protected from iodide. This, of
course, also assumes that we are primarily examining dy-
namic, and not static, quenching events. However, the
Stern-Volmer plots are relatively linear and do not suggest
the presence of a significant static quenching component.
The assumptions that the FHS fluorescence of relaxed
myofibrils is indicative of detached cross-bridges, and that
the FHS fluorescence of rigor myofibrils is indicative of
strongly bound cross-bridges, are probably valid given the
similarity between the solvent quenching behavior of these
preparations with analogous experiments using purified ac-
tin and FHS-S1 (MacLean et al., 2000). The similarity of
these results also suggests that we are primarily observing
fluorescence from FHS probes at Lys-553 of the myosin
heavy chain. The assumption that FHS probes on actin-
attached myosin heads in actively contracting myofibrils
behave similarly to those in actin-bound cross-bridges in
rigor myofibrils is the most speculative of our assumptions.
Therefore, the possibility exists that we are under- or over-
estimating the fraction of myosin heads strongly bound to
actin in calcium-activated myofibrils, if the Stern-Volmer
quenching constant for actively bound cross-bridges is ac-
tually higher or lower than that of rigor bound cross-bridges.
However, it is likely that myosin must adopt a strongly
bound conformation similar to that observed in rigor in
order to generate and maintain force during an isometric
contraction. Furthermore, intrinsic fluorescence from Trp-
546, located on the same -helix as Lys-553 of the myosin
heavy chain, indicates that this region interacts directly with
actin in the strongly bound state and forms a stable complex
in both the ADP-rigor and rigor states (Yengo et al., 1998;
1999). Thus, the value of 29% for the fraction of strongly
bound myosin heads in the calcium-activated FHS-myofi-
brils by iodide quenching is probably a reasonable estimate.
Other studies have attempted to determine the fraction of
actin-bound cross-bridges (fB) in actively contracting, iso-
metric muscle fibers and myofibrils in the past. Mechanical
stiffness measurements have suggested that as much as 80%
of the cross-bridges may be bound to actin in a strongly
bound state during isometric contractions (Goldman and
Simmons, 1977). However, this is likely to be an over-
estimate given that high-resolution x-ray diffraction (Hux-
ley et al., 1994; Wakabayashi et al., 1994) and mechanical
(Higuchi et al., 1995) studies indicate that more than half of
the sarcomere’s compliance may lie outside of the cross-
bridge in the thick and thin filaments. More recent estimates
from mechanical stiffness measurements place the value for
the fraction of actin-bound cross-bridges in isometric mus-
cle fibers at 43% (Linari et al., 1998). However, 43% is still
significantly higher than estimates of fB made from EPR
spectroscopy and proteolytic digestion experiments, which
are in the range of 20–25%. Cooke et al. (1982) observed
that 20% of the myosin heads in a spin-labeled, isometri-
cally contracting muscle fiber have a similar orientation to
cross-bridges in a rigor muscle fiber, while the other 80%
are identical to the detached cross-bridges in relaxed muscle
fibers. There may, in fact, be fewer strongly bound cross-
bridges in the spin-labeled muscle fibers due to alterations
in the kinetics of the ATPase cycle in SH-1 modified
myosins (Ostap et al., 1993). However, Duong and Reisler
(1989) showed that 25% of the myosin heads in calcium-
activated EDC-cross-linked myofibrils, which are not mod-
ified at SH-1, are protected from tryptic digestion at the
50/20 kD junction in the myosin heavy chain. Berger and
Thomas (1993) confirmed the result of Duong and Reisler
(1989) and showed that this value increases to 37% at low
ionic strength, presumably due to additional contributions
from weakly bound cross-bridges.
There is a possible resolution to the discrepancy between
the more recent stiffness measurements (fB  43%) and the
EPR and proteolytic digestion studies (fB  20–25%).
Tryptic susceptibility of the 50/20 kD junction and spectro-
scopic probes are sensitive to the interaction of individual
myosin heads with actin, while stiffness measurements are
only sensitive to the interaction of the entire cross-bridge
(i.e., double-headed myosin molecules) with actin. Thus, if
the compliance within the cross-bridge lies outside of the
myosin head (for example in the S2 region), and each
cross-bridge binds to actin with one of its two heads, then
40% of the cross-bridges could be bound to actin with only
20% of the total number of myosin heads. However, if any
of the cross-bridge compliance resides within the S1 portion
of the myosin molecule itself, then the stiffness results are
still in contrast to the proteolytic digestion and spectro-
scopic data.
Our current results (fB  29%) are in between the esti-
mates from mechanical stiffness measurements (fB  43%)
and those from other techniques (fB  20–25%). Although
the error in our estimation is relatively high (12%), it is
possible that the estimates from different techniques reflect
real differences in the fraction of actin-bound myosin heads
in skeletal muscle myofibrils. One possible explanation may
be the fact that we, by necessity for the iodide quenching
effects, carried our experiments out at low ionic strength,
while most of the previous studies were performed at more
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physiological ionic strengths (150–200 mM). Berger and
Thomas (1993) found a higher fraction of actin-bound
cross-bridges in isometrically contracting EDC-cross-linked
myofibrils at low ionic strength (fB  37%) than at physi-
ological ionic strength (fB 24%). This difference could be
due to the presence of more weakly and/or strongly bound
cross-bridges at low ionic strength than at physiological
ionic strength. Protection from proteolytic digestion of the
50/20 kD junction in myosin by actin can be sensitive to
weakly bound as well as strongly bound cross-bridges.
However, FHS-S1 is not protected by actin from iodide
quenching in the weakly bound states (MacLean et al.,
2000), and this is therefore likely to be true in FHS-myo-
fibrils as well. Therefore, the estimate of 29% obtained in
this work probably represents myosin heads bound to actin
in a strongly bound complex during isometric contractions
within the myofilament lattice at low ionic strength, and this
value would likely decrease to 20–25% with increasing
ionic strength. The 9% discrepancy between the value of fB
measured in this work (29%) and that measured previously
by Berger and Thomas (1993) under similar conditions
(37%) is likely due to the sensitivity of proteolytic digestion
experiments to the presence of weakly bound cross-bridges.
Clearly, however, a real-time assay for the detection of
actin-bound myosin heads in myofilament lattice of mus-
cle fibers and myofibrils is advantageous to indirect
mechanical measurements that cannot differentiate be-
tween singly bound myosin heads and doubly bound myosin
cross-bridges.
Future directions
Conventional in vitro motility assays have been used to
estimate the duty cycle (i.e., the fraction of the ATPase
cycle in which myosin interacts strongly with actin) during
unloaded filament sliding. Several groups (Uyeda et al.,
1990; Harris and Warshaw, 1993) have reported low duty
cycle estimates (5%), consistent with a tight chemome-
chanical coupling model in which the hydrolysis of one
molecule of ATP by myosin results in a single productive
interaction with actin. Measurements of unitary displace-
ments and forces from single myosin heads using optical
laser traps (Finer et. al, 1994; Molloy et al., 1995; Guilford
et al., 1997) have also been consistent with tight coupling
between the mechanical and chemical ATPase cycles of
myosin. Conversely, evidence for a loosely coupled chemo-
mechanical cycle, in which the hydrolysis of one molecule
of ATP by myosin results in multiple productive interac-
tions with actin, has been obtained from mechanical in vitro
studies, both in solution and in single muscle fibers. Esti-
mates of the distance a single cross-bridge can interact with
the thin filament per ATP hydrolyzed during isotonic short-
ening has been measured in single muscle fibers and found
to be greater than the size of the myosin head or actin
monomer (Higuchi and Goldman, 1991; 1995). The inter-
action distance measured in these experiments, however, is
directly proportional to cross-bridge attachment, which was
determined by traditional stiffness measurements. There-
fore, if the stiffness measurements do indeed over-estimate
the fraction of actin-bound cross-bridges in actively con-
tracting muscle fibers due to myofilament compliance, then
the estimates of interaction distance will be over-estimated
by the same amount. In solution, force fluctuations of a few
myosin molecules interacting with a single actin filament
have been shown to be high under large (near isometric)
loads, suggesting a low duty cycle, but small under un-
loaded conditions, suggesting a high duty cycle (Ishijima et
al., 1991). This is consistent with the high estimates of duty
cycle (80%) during filament sliding in the in vitro motility
assay by Harada et al. (1990). Yanagida’s laboratory has
also demonstrated that a single myosin head can make
repeated powerstrokes per ATP molecule hydrolyzed (Kita-
mura et al., 1999) and that the hydrolysis of ATP and the
myosin powerstroke can be temporally uncoupled from
each other (Ishijima et al., 1998). These results are in direct
contrast with conventional models of muscle contraction in
which the biochemical and mechanical contractile cycles
are tightly coupled.
The technique developed in this work and the accompa-
nying paper (MacLean et al., 2000) may be useful for
addressing the current controversies involving the chemo-
mechanical coupling ratio during unloaded myofilament
sliding. Because iodide quenching of FHS-S1 and FHS-
myofibrils at low ionic strength is sensitive to strong bind-
ing interactions between actin and myosin, it should be
possible to directly examine the duty cycle in both isoton-
ically shortening muscle fibers labeled with FHS, and dur-
ing unloaded actin filament sliding in conventional in vitro
motility assays using FHS-labeled whole myosin. Solvent
quenching is an excited state reaction and occurs on the
nanosecond time scale, and thus such time-resolved exper-
iments should be achievable. Experiments could be done at
an intermediate iodide concentration in which the fluores-
cence from actin-bound and detached myosin heads is sig-
nificantly different. In single muscle fibers this signal could
easily be calibrated as function of isometric force, varying
either the thick and thin filament overlap (i.e., sarcomere
length) or the concentration of activating calcium. The fact
that myosin appears to be predominantly labeled at Lys-553
in skeletal muscle myofibrils suggests that this technique
can be extended to purified myosin for the in vitro motility
assays as well as to single, skinned muscle fibers. We have
already demonstrated that the duty cycle for isometrically
contracting skeletal muscle myofibrils can be accurately
determined (fB  29%). The challenge remains to make
similar estimates for conditions other than isometric in order
to answer critical questions remaining about energy trans-
duction during muscle contraction.
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